Aridis Pharmaceuticals Inc. (ARDS) SEC filings
ARDS SEC filings moved a median of -4.73% by the close. ARDS SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ARDS overview →
10 measured ARDS SEC filing events.
Where these ARDS SEC filings landedvs 10 measured ARDS SEC filing reactions
| Middle 50% of ARDS SEC filing reactions | -15.27% to +8.70% |
|---|---|
| Median reaction (to close) | -4.73% |
| Measured reactions | 10 |
Point-in-time · zero look-ahead
Half of the 10 ARDS SEC filing events with a measured close landed between -15.27% and +8.70%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Aridis Pharmaceuticals, For: Jun 24 | SEC filing · Form 8-K | +13.27% | -19.42% | |
| Form 8-K Aridis Pharmaceuticals, For: Jan 12 | SEC filing · Form 8-K | +0.00% | +5.80% | |
| Form 8-K Aridis Pharmaceuticals, For: Dec 16 | SEC filing · Form 8-K | — | -15.27% | |
| Form DEFA14A Aridis Pharmaceuticals, | SEC filing · Form DEFA14A | — | -15.27% | |
| Form DEFA14A Aridis Pharmaceuticals, | SEC filing · Form DEFA14A | +0.00% | -15.27% | |
| Form 10-Q Aridis Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +16.39% | |
| Form 8-K Aridis Pharmaceuticals, For: Nov 03 | SEC filing · Form 8-K | -6.25% | -16.67% | |
| Form ARS Aridis Pharmaceuticals, For: Dec 31 | SEC filing · Form ARS | +0.00% | +8.70% | |
| Form DEF 14A Aridis Pharmaceuticals, For: Nov 02 | SEC filing · Form DEF | +0.00% | +8.70% | |
| Form DEFA14A Aridis Pharmaceuticals, | SEC filing · Form DEFA14A | +0.00% | +8.70% |
Keep exploring
More ARDS: earnings → · analyst actions → · ARDS overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Medmira Inc (MIR_CDNX) | 31 | 0.00% | 10% |
| BIOFORCE NANOSCIENCES HLD (BFNH) | 30 | +0.30% | 50% |
| Evelo Biosciences, Inc. (EVLO) | 28 | -3.02% | 36% |
| Nu-Med Plus Inc. Com (NUMD) | 28 | 0.00% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.